These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29668098)

  • 1. Defining the psychological comorbidity in vitiligo: systematically casting the net wide.
    Thomson J
    Br J Dermatol; 2018 Apr; 178(4):826. PubMed ID: 29668098
    [No Abstract]   [Full Text] [Related]  

  • 2. Comorbid diagnosis of systemic lupus erythematosus in vitiligo: a systematic review and meta-analysis.
    Li HO; Bailey AMJ; Pastukhova E; Tan MG; Kirchhof MG
    Br J Dermatol; 2023 Feb; 188(3):440-441. PubMed ID: 36680305
    [No Abstract]   [Full Text] [Related]  

  • 3. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study.
    Lee YB; Kim S; Kim HS
    J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730
    [No Abstract]   [Full Text] [Related]  

  • 4. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy.
    Mansour MR; Abushukur Y; Rehman RA; Shah C; Mehregan D
    J Am Acad Dermatol; 2022 Dec; 87(6):1445-1448. PubMed ID: 35995610
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitiligo in underrepresented communities: An All of Us database analysis.
    Ahmed F; Moseley I; Ragi SD; Ouellette S; Rao B
    J Am Acad Dermatol; 2023 Apr; 88(4):945-948. PubMed ID: 36414097
    [No Abstract]   [Full Text] [Related]  

  • 7. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
    Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation between Association of Psoriasis and Vitiligo.
    Yazdanpanah MJ; Banihashemi M; Pezeshkpoor F; Moradifar M; Feli S; Esmaeili H
    J Cutan Med Surg; 2015; 19(2):140-3. PubMed ID: 25775635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of COVID-19 related complications in vitiligo patients: A database study.
    Raiker R; Pakhchanian H; Salingaros S; Helm M
    J Dtsch Dermatol Ges; 2022 Nov; 20(11):1505-1508. PubMed ID: 36210055
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of factors associated with health-related quality of life and psychological distress in vitiligo.
    Bonotis K; Pantelis K; Karaoulanis S; Katsimaglis C; Papaliaga M; Zafiriou E; Tsogas P
    J Dtsch Dermatol Ges; 2016 Jan; 14(1):45-9. PubMed ID: 26713637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment Loss in Patients with Large Congenital Melanocytic Nevi: Various Clinical Presentations Documented in a Large Series.
    Polat Ekinci A; Kiliç S; Baykal C
    Pediatr Dermatol; 2016 May; 33(3):307-10. PubMed ID: 26935480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics.
    Nicolaidou E; Antoniou C; Miniati A; Lagogianni E; Matekovits A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2012 Jun; 66(6):954-8. PubMed ID: 21982634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of vitiligo and associated comorbidities in Korea.
    Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH
    Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
    Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent: a retrospective analysis in 1307 patients aged ≥ 50 years.
    Teulings HE; Ceylan E; Overkamp M; Vrijman C; Bos JD; Nijsten TE; Wolkerstorfer A; Luiten RM; van der Veen JP
    Br J Dermatol; 2016 Oct; 175(4):821-4. PubMed ID: 27042816
    [No Abstract]   [Full Text] [Related]  

  • 16. Alopecia areata and vitiligo - partners in crime or a case of false alibis.
    Tobin DJ
    Exp Dermatol; 2014 Mar; 23(3):153-4. PubMed ID: 24372718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age of onset on disease characteristics in non-segmental vitiligo.
    Solak B; Dikicier BS; Cosansu NC; Erdem T
    Int J Dermatol; 2017 Mar; 56(3):341-345. PubMed ID: 28054375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities associated with vitiligo: a ten-year retrospective study.
    Sheth VM; Guo Y; Qureshi AA
    Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities in vitiligo: comprehensive review.
    Dahir AM; Thomsen SF
    Int J Dermatol; 2018 Oct; 57(10):1157-1164. PubMed ID: 29808541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Vitiligo and Alopecia Areata With Atopic Dermatitis: A Systematic Review and Meta-analysis.
    Mohan GC; Silverberg JI
    JAMA Dermatol; 2015 May; 151(5):522-8. PubMed ID: 25471826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.